|
G |
Afp |
alpha-fetoprotein |
affects binding |
EXP |
fisetin binds to AFP protein |
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases localization |
ISO |
fisetin results in increased localization of AIFM1 protein |
CTD |
PMID:28181380 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
EXP ISO |
fisetin results in increased phosphorylation of AKT1 protein fisetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:20153296 PMID:25428606 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
fisetin inhibits the reaction [Lead results in increased expression of APP protein] |
CTD |
PMID:31539617 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases expression |
ISO |
fisetin inhibits the reaction [Dihydrotestosterone results in increased expression of AR protein]; fisetin inhibits the reaction [Metribolone results in increased folding of and results in increased stability of AR protein]; fisetin results in decreased stability of and results in decreased expression of AR protein fisetin results in decreased expression of AR mRNA |
CTD |
PMID:18922931 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions increases expression |
ISO |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6 protein] |
CTD |
PMID:28181380 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atf6b |
activating transcription factor 6 beta |
multiple interactions increases expression |
ISO |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6B protein] |
CTD |
PMID:28181380 |
|
NCBI chr20:4,090,921...4,098,920
Ensembl chr20:4,090,921...4,098,894
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions |
ISO |
[Cisplatin co-treated with fisetin] results in increased expression of BAK1 protein |
CTD |
PMID:21216935 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression affects expression |
EXP ISO |
fisetin inhibits the reaction [Cisplatin results in increased expression of BAX protein] fisetin results in increased expression of BAX protein fisetin inhibits the reaction [Lead results in increased expression of BAX protein] fisetin affects the expression of BAX protein [fisetin co-treated with Paclitaxel] results in increased expression of BAX mRNA; [U 0126 co-treated with pyrazolanthrone] inhibits the reaction [fisetin results in increased expression of BAX protein]; [XMU-MP-1 co-treated with U 0126 co-treated with pyrazolanthrone] inhibits the reaction [fisetin results in increased expression of BAX protein]; pyrazolanthrone inhibits the reaction [fisetin results in increased expression of BAX protein]; U 0126 inhibits the reaction [fisetin results in increased expression of BAX protein]; XMU-MP-1 inhibits the reaction [fisetin results in increased expression of BAX protein] |
CTD |
PMID:25184746 PMID:26884726 PMID:28181380 PMID:31044527 PMID:31539617 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP ISO |
fisetin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] fisetin inhibits the reaction [Lead results in decreased expression of BCL2 protein] fisetin results in decreased expression of BCL2 protein [fisetin co-treated with Paclitaxel] results in increased expression of BCL2 mRNA |
CTD |
PMID:25184746 PMID:26884726 PMID:28181380 PMID:31539617 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions decreases expression |
ISO |
[pyrazolanthrone co-treated with U 0126] inhibits the reaction [fisetin results in decreased expression of BCL2L1 protein]; [XMU-MP-1 co-treated with pyrazolanthrone co-treated with U 0126] inhibits the reaction [fisetin results in decreased expression of BCL2L1 protein]; pyrazolanthrone inhibits the reaction [fisetin results in decreased expression of BCL2L1 protein]; U 0126 inhibits the reaction [fisetin results in decreased expression of BCL2L1 protein]; XMU-MP-1 inhibits the reaction [fisetin results in decreased expression of BCL2L1 protein] |
CTD |
PMID:31044527 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
EXP |
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of BDNF protein] |
CTD |
PMID:30890323 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO |
fisetin promotes the reaction [Lead results in increased expression of BECN1 protein] |
CTD |
PMID:31539617 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions affects expression increases cleavage |
ISO |
[Cisplatin co-treated with fisetin] results in increased cleavage of BID protein fisetin affects the expression of BID protein fisetin results in increased cleavage of BID protein |
CTD |
PMID:21216935 PMID:28181380 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
[Cisplatin co-treated with fisetin] results in decreased expression of BIRC5 protein |
CTD |
PMID:21216935 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Capn1 |
calpain 1 |
increases expression multiple interactions |
ISO |
fisetin results in increased expression of CAPN1 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CAPN1 protein] |
CTD |
PMID:28181380 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Capn2 |
calpain 2 |
increases expression multiple interactions |
ISO |
fisetin results in increased expression of CAPN2 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CAPN2 protein] |
CTD |
PMID:28181380 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Casp12 |
caspase 12 |
increases expression multiple interactions |
ISO |
fisetin results in increased expression of CASP12 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CASP12 protein] |
CTD |
PMID:28181380 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage increases activity |
ISO EXP |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased activity of CASP3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [fisetin results in increased activity of CASP3 protein]; [Cisplatin co-treated with fisetin] results in increased cleavage of and results in increased activity of CASP3 protein; [fisetin co-treated with Paclitaxel] results in increased expression of CASP3 mRNA; [U 0126 co-treated with pyrazolanthrone] inhibits the reaction [fisetin results in increased cleavage of CASP3 protein]; [XMU-MP-1 co-treated with U 0126 co-treated with pyrazolanthrone] inhibits the reaction [fisetin results in increased cleavage of CASP3 protein]; fisetin inhibits the reaction [Silicon Dioxide results in increased expression of CASP3 mRNA]; pyrazolanthrone inhibits the reaction [fisetin results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [fisetin results in increased cleavage of CASP3 protein]; XMU-MP-1 inhibits the reaction [fisetin results in increased cleavage of CASP3 protein] fisetin inhibits the reaction [Lead results in increased cleavage of CASP3 protein] fisetin inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein] |
CTD |
PMID:21216935 PMID:21964635 PMID:22931364 PMID:25184746 PMID:26884726 PMID:28181380 PMID:31044527 PMID:31539617 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression multiple interactions |
ISO |
fisetin results in increased expression of CASP4 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of CASP4 protein] |
CTD |
PMID:28181380 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
[Cisplatin co-treated with fisetin] promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein]; fisetin promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein] |
CTD |
PMID:21216935 |
|
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases activity |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [fisetin results in increased activity of CASP8 protein]; [Cisplatin co-treated with fisetin] results in increased cleavage of and results in increased activity of CASP8 protein; fisetin results in increased cleavage of and results in increased activity of CASP8 protein |
CTD |
PMID:21216935 PMID:21964635 PMID:28181380 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases activity |
ISO EXP |
[Cisplatin co-treated with fisetin] promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein]; [Cisplatin co-treated with fisetin] results in increased cleavage of and results in increased activity of CASP9 protein; fisetin promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein]; fisetin results in increased cleavage of and results in increased activity of CASP9 protein fisetin results in increased activity of CASP9 protein fisetin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] |
CTD |
PMID:21216935 PMID:25184746 PMID:28181380 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
fisetin inhibits the reaction [Cisplatin results in decreased activity of CAT protein] |
CTD |
PMID:25184746 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression multiple interactions |
ISO |
fisetin results in decreased expression of CCN2 protein [pyrazolanthrone co-treated with U 0126] inhibits the reaction [fisetin results in decreased expression of CCN2 protein]; [XMU-MP-1 co-treated with pyrazolanthrone co-treated with U 0126] inhibits the reaction [fisetin results in decreased expression of CCN2 protein]; pyrazolanthrone inhibits the reaction [fisetin results in decreased expression of CCN2 protein]; U 0126 inhibits the reaction [fisetin results in decreased expression of CCN2 protein]; XMU-MP-1 inhibits the reaction [fisetin results in decreased expression of CCN2 protein] |
CTD |
PMID:31044527 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
fisetin results in decreased expression of CCNA2 protein |
CTD |
PMID:28181380 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions decreases expression |
ISO |
[Cisplatin co-treated with fisetin] results in decreased expression of CCNB1 protein fisetin results in decreased expression of CCNB1 protein |
CTD |
PMID:21216935 PMID:28181380 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cd40 |
CD40 molecule |
multiple interactions |
ISO |
fisetin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] |
CTD |
PMID:16601352 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
decreases expression |
ISO |
fisetin results in decreased expression of CD44 protein |
CTD |
PMID:30802432 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
fisetin results in decreased expression of CDC25C protein |
CTD |
PMID:28181380 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdh1 |
cadherin 1 |
increases expression multiple interactions |
ISO |
fisetin results in increased expression of CDH1 protein fisetin inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of CDH1 protein]; fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of CDH1 protein] |
CTD |
PMID:30802432 PMID:31606474 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CDH2 protein] |
CTD |
PMID:31606474 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
fisetin results in decreased expression of CDK1 protein |
CTD |
PMID:28181380 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
fisetin results in decreased expression of CDK2 protein |
CTD |
PMID:28181380 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases expression |
ISO |
[Cisplatin co-treated with fisetin] results in increased expression of CDKN1A protein fisetin results in increased expression of CDKN1A protein |
CTD |
PMID:21216935 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression |
ISO |
fisetin results in increased expression of CHEK1 protein |
CTD |
PMID:28181380 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases expression |
ISO |
fisetin results in increased expression of CHEK2 protein |
CTD |
PMID:28181380 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions |
ISO |
[fisetin co-treated with COMT protein] results in decreased activity of DNMT1 protein |
CTD |
PMID:16037419 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cplx2 |
complexin 2 |
multiple interactions |
EXP |
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of CPLX2 mRNA] |
CTD |
PMID:30890323 |
|
NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
fisetin inhibits the reaction [Lead results in decreased phosphorylation of CREB1 protein] |
CTD |
PMID:31539617 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases expression multiple interactions |
ISO |
fisetin results in decreased expression of CTNNB1 protein fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CTNNB1 protein] |
CTD |
PMID:30802432 PMID:31606474 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
fisetin inhibits the reaction [Cisplatin results in increased expression of CYBB mRNA] |
CTD |
PMID:25184746 |
|
NCBI chr X:13,360,583...13,392,517
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
fisetin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:29584932 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
EXP |
fisetin inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA] |
CTD |
PMID:23524313 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of DDIT3 protein] |
CTD |
PMID:28181380 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddn |
dendrin |
multiple interactions |
EXP |
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of DDN mRNA] |
CTD |
PMID:30890323 |
|
NCBI chr 7:129,953,317...129,957,299
Ensembl chr 7:129,953,318...129,957,341
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
increases activity |
ISO |
fisetin results in increased activity of DIO2 protein |
CTD |
PMID:17327447 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
multiple interactions |
ISO |
fisetin inhibits the reaction [Lead results in decreased expression of DLG4 protein] |
CTD |
PMID:31539617 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
ISO |
[fisetin co-treated with COMT protein] results in decreased activity of DNMT1 protein |
CTD |
PMID:16037419 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EGFR protein modified form] |
CTD |
PMID:31606474 |
|
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
ISO |
[fisetin co-treated with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid] results in decreased expression of EIF2AK3 protein |
CTD |
PMID:28181380 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Endog |
endonuclease G |
increases localization |
ISO |
fisetin results in increased localization of ENDOG protein |
CTD |
PMID:28181380 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
fisetin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]] |
CTD |
PMID:20153296 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
multiple interactions |
ISO |
fisetin results in decreased phosphorylation of and results in increased degradation of ERBB2 protein |
CTD |
PMID:30431692 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
decreases expression |
ISO |
fisetin results in decreased expression of ERBB3 protein |
CTD |
PMID:30431692 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Exoc8 |
exocyst complex component 8 |
multiple interactions |
EXP |
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of EXOC8 mRNA] |
CTD |
PMID:30890323 |
|
NCBI chr19:52,855,010...52,857,499
Ensembl chr19:52,852,578...52,857,491
|
|
G |
Faslg |
Fas ligand |
multiple interactions increases expression |
ISO |
[Cisplatin co-treated with fisetin] results in increased expression of FASLG protein fisetin results in increased expression of FASLG protein |
CTD |
PMID:21216935 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
fisetin results in increased expression of and affects the localization of FOS protein |
CTD |
PMID:31044527 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
EXP |
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of GDNF protein] |
CTD |
PMID:30890323 |
|
NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
fisetin inhibits the reaction [methylmercuric chloride results in increased expression of GFAP protein] |
CTD |
PMID:30890323 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of GSK3B protein modified form] |
CTD |
PMID:31606474 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
fisetin inhibits the reaction [Cisplatin results in decreased activity of GSR protein] |
CTD |
PMID:25184746 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression increases activity |
EXP ISO |
cobaltous chloride promotes the reaction [fisetin results in increased activity of HIF1A protein]; fisetin promotes the reaction [cobaltous chloride results in increased activity of HIF1A protein]; fisetin results in increased expression of and affects the localization of HIF1A protein fisetin promotes the reaction [Oxygen deficiency promotes the reaction [HIF1A protein binds to EP300 protein]]; fisetin promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein] fisetin results in increased expression of HIF1A mRNA |
CTD |
PMID:20153296 PMID:25428606 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
fisetin results in increased expression of HMOX1 protein fisetin results in increased expression of HMOX1 mRNA; fisetin results in increased expression of HMOX1 protein Cycloheximide inhibits the reaction [fisetin results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [fisetin results in increased expression of HMOX1 protein]; HMOX1 protein promotes the reaction [fisetin results in decreased expression of MMP2 protein]; HMOX1 protein promotes the reaction [fisetin results in decreased expression of MMP9 protein]; NFE2L2 protein promotes the reaction [fisetin results in increased expression of HMOX1 protein] |
CTD |
PMID:16799064 PMID:30076913 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
ISO |
fisetin results in increased expression of HSPA5 protein 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of HSPA5 protein] |
CTD |
PMID:28181380 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL13 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA] |
CTD |
PMID:12789233 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein] |
CTD |
PMID:18958421 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions decreases expression |
ISO |
fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL4 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA] fisetin results in decreased expression of IL4 protein |
CTD |
PMID:12789233 PMID:16343431 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
ISO |
fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL5 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA] |
CTD |
PMID:12789233 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; fisetin inhibits the reaction [Silicon Dioxide results in increased expression of IL6 mRNA] fisetin inhibits the reaction [Lead results in increased expression of IL6 protein] |
CTD |
PMID:18958421 PMID:22931364 PMID:31539617 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO |
fisetin inhibits the reaction [INS1 protein affects the localization of SLC2A4 protein]; fisetin inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose] |
CTD |
PMID:18591783 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
fisetin results in increased phosphorylation of and affects the localization of JUN protein |
CTD |
PMID:31044527 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lats2 |
large tumor suppressor kinase 2 |
increases phosphorylation |
ISO |
fisetin results in increased phosphorylation of LATS2 protein |
CTD |
PMID:31044527 |
|
NCBI chr15:31,825,068...31,877,193
Ensembl chr15:31,825,092...31,877,220
|
|
G |
Lin7a |
lin-7 homolog A, crumbs cell polarity complex component |
multiple interactions |
EXP |
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of LIN7A mRNA] |
CTD |
PMID:30890323 |
|
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
|
|
G |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
increases expression |
ISO |
fisetin results in increased expression of MAP3K20 protein |
CTD |
PMID:31044527 |
|
NCBI chr 3:57,128,561...57,289,943
Ensembl chr 3:57,130,551...57,289,626
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO EXP |
fisetin results in increased phosphorylation of MAPK1 protein fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:21964635 PMID:25428606 PMID:31044527 PMID:31606474 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO EXP |
fisetin results in increased phosphorylation of MAPK3 protein fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:21964635 PMID:25428606 PMID:31044527 PMID:31606474 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
fisetin inhibits the reaction [Lead results in increased phosphorylation of MAPT protein] |
CTD |
PMID:31539617 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mme |
membrane metallo-endopeptidase |
multiple interactions |
ISO |
fisetin inhibits the reaction [Lead results in decreased expression of MME protein] |
CTD |
PMID:31539617 |
|
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO |
HMOX1 protein promotes the reaction [fisetin results in decreased expression of MMP2 protein]; NFE2L2 protein promotes the reaction [fisetin results in decreased expression of MMP2 protein]; tin protoporphyrin IX inhibits the reaction [fisetin results in decreased expression of MMP2 mRNA]; tin protoporphyrin IX inhibits the reaction [fisetin results in decreased expression of MMP2 protein]; zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP2 mRNA]; zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP2 protein] fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of and results in increased activity of MMP2 protein] fisetin results in decreased expression of MMP2 mRNA; fisetin results in decreased expression of MMP2 protein |
CTD |
PMID:30076913 PMID:31606474 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
fisetin inhibits the reaction [Silicon Dioxide results in increased expression of MMP9 mRNA]; fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of and results in increased activity of MMP9 protein] HMOX1 protein promotes the reaction [fisetin results in decreased expression of MMP9 protein]; NFE2L2 protein promotes the reaction [fisetin results in decreased expression of MMP9 protein]; tin protoporphyrin IX inhibits the reaction [fisetin results in decreased expression of MMP9 mRNA]; tin protoporphyrin IX inhibits the reaction [fisetin results in decreased expression of MMP9 protein]; zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 mRNA]; zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 protein] fisetin results in decreased expression of MMP9 mRNA; fisetin results in decreased expression of MMP9 protein |
CTD |
PMID:22931364 PMID:30076913 PMID:31606474 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
fisetin inhibits the reaction [Cisplatin results in increased activity of MPO protein] |
CTD |
PMID:25184746 |
|
NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
ISO |
fisetin inhibits the reaction [Lead results in increased expression of MYD88 protein] |
CTD |
PMID:31539617 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nfatc2 |
nuclear factor of activated T-cells 2 |
multiple interactions |
ISO |
fisetin inhibits the reaction [Calcimycin results in increased activity of NFATC2 protein] |
CTD |
PMID:12789233 |
|
NCBI chr 3:157,195,970...157,328,640
Ensembl chr 3:157,198,872...157,328,325
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions |
ISO |
fisetin results in increased expression of NFE2L2 protein NFE2L2 protein promotes the reaction [fisetin results in decreased expression of MMP2 protein]; NFE2L2 protein promotes the reaction [fisetin results in decreased expression of MMP9 protein]; NFE2L2 protein promotes the reaction [fisetin results in increased expression of HMOX1 protein] |
CTD |
PMID:16799064 PMID:30076913 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression |
ISO |
fisetin results in decreased expression of NFKB1 protein |
CTD |
PMID:30802432 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
fisetin inhibits the reaction [Cisplatin results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:25184746 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP ISO |
fisetin inhibits the reaction [Cisplatin results in increased expression of NOS2 protein] fisetin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:17177504 PMID:25184746 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
EXP |
fisetin inhibits the reaction [Cisplatin results in increased expression of NOX4 mRNA] |
CTD |
PMID:25184746 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
fisetin inhibits the reaction [Cisplatin results in decreased activity of NQO1 protein] |
CTD |
PMID:25184746 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases expression |
ISO |
fisetin results in increased expression of NR1I2 mRNA |
CTD |
PMID:29933105 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nrgn |
neurogranin |
multiple interactions |
EXP |
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of NRGN mRNA] |
CTD |
PMID:30890323 |
|
NCBI chr 8:37,255,462...37,263,659
Ensembl chr 8:37,256,930...37,257,516
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
decreases activity |
ISO |
fisetin results in decreased activity of PARP1 protein |
CTD |
PMID:17884996 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Prom1 |
prominin 1 |
decreases expression |
ISO |
fisetin results in decreased expression of PROM1 protein |
CTD |
PMID:30802432 |
|
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein] fisetin inhibits the reaction [Lead affects the localization of RELA protein] fisetin inhibits the reaction [Cisplatin affects the localization of and results in increased activity of RELA protein] |
CTD |
PMID:18958421 PMID:25184746 PMID:31539617 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
fisetin inhibits the reaction [Lead results in decreased expression of SIRT1 protein]; fisetin results in increased activity of and results in increased phosphorylation of SIRT1 protein |
CTD |
PMID:31539617 PMID:34216621 |
|
NCBI chr20:25,307,143...25,329,260
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
EXP |
[fisetin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate |
CTD |
PMID:17108059 |
|
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
multiple interactions |
ISO |
[fisetin co-treated with Oxygen deficiency] results in decreased expression of SLC2A3 mRNA |
CTD |
PMID:20153296 |
|
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
fisetin inhibits the reaction [INS1 protein affects the localization of SLC2A4 protein] |
CTD |
PMID:18591783 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Snap25 |
synaptosome associated protein 25 |
multiple interactions |
ISO |
fisetin inhibits the reaction [Lead results in decreased expression of SNAP25 protein] |
CTD |
PMID:31539617 |
|
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
increases expression |
ISO |
fisetin results in increased expression of SREBF2 protein alternative form |
CTD |
PMID:23524313 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions decreases expression |
ISO |
fisetin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of STAT3 protein] fisetin results in decreased expression of STAT3 protein |
CTD |
PMID:20153296 PMID:30802432 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stx1a |
syntaxin 1A |
multiple interactions |
EXP |
fisetin inhibits the reaction [methylmercuric chloride results in decreased expression of STX1A mRNA] |
CTD |
PMID:30890323 |
|
NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
fisetin inhibits the reaction [Lead results in increased expression of TLR4 protein] |
CTD |
PMID:31539617 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein] fisetin inhibits the reaction [Lead results in increased expression of TNF protein] fisetin inhibits the reaction [Cisplatin results in increased expression of TNF protein] |
CTD |
PMID:18958421 PMID:25184746 PMID:31539617 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions affects localization increases expression |
ISO EXP |
[Cisplatin co-treated with fisetin] affects the localization of TP53 protein; [Cisplatin co-treated with fisetin] results in increased expression of TP53 protein; [Cisplatin co-treated with fisetin] results in increased phosphorylation of TP53 protein; fisetin inhibits the reaction [Silicon Dioxide results in increased expression of TP53 mRNA]; SB 203580 inhibits the reaction [[Cisplatin co-treated with fisetin] results in increased phosphorylation of TP53 protein] fisetin inhibits the reaction [Cisplatin results in increased expression of TP53 protein] fisetin affects the localization of TP53 protein fisetin results in increased expression of TP53 protein |
CTD |
PMID:21216935 PMID:22931364 PMID:25184746 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of fisetin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a8 |
UDP glucuronosyltransferase family 1 member A8 |
increases glucuronidation |
ISO |
UGT1A8 protein results in increased glucuronidation of fisetin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,727,094...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of fisetin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
fisetin inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; fisetin inhibits the reaction [Oxygen deficiency results in increased secretion of VEGFA protein]; fisetin promotes the reaction [Oxygen deficiency results in increased expression of and results in increased localization of VEGFA protein] |
CTD |
PMID:20153296 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
decreases expression multiple interactions |
ISO |
fisetin results in decreased expression of VIM protein fisetin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of VIM protein] |
CTD |
PMID:30802432 PMID:31606474 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Yap1 |
Yes1 associated transcriptional regulator |
multiple interactions |
ISO |
fisetin results in increased phosphorylation of and affects the localization of YAP1 protein |
CTD |
PMID:31044527 |
|
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
|
|